Reaching the Hard to Reach: Characteristics of Patients Who Received a COVID-19 Vaccine in the Emergency Department.

In February 2021, the U.S. Food and Drug Administration (FDA) provided Emergency Use Authorization for the Janssen vaccine- the first one-dose COVID-19 vaccine to become available in the U.S. The one-dose regimen expanded opportunity to vaccinate in settings that can reach vulnerable communities for which returning to a site for a second vaccine dose may prove difficult. With 139 million visits annually in the U.S.1 and a tendency to serve in a safety net capacity for underserved patients2 , the emergency department (ED) is one such setting. This article is protected by copyright. All rights reserved.